Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Diamandis

Showing results (61-70 of 787) with videos related to

Pageof 79
Sort By:
Clinical Biochemistry|April 25, 2017
The emerging landscape of scientific publishingClare Fiala, Eleftherios P Diamandis
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 3, 2008
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expressionMiltiadis Paliouras, Eleftherios P Diamandis
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancerK Angelopoulou, E P Diamandis
BMC Medicine|October 5, 2018
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detectionClare Fiala, Eleftherios P Diamandis
Clinical Chemistry|June 5, 2016
Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for AntidopingNatasha Musrap, Eleftherios P Diamandis
Breast Cancer Research and Treatment|August 10, 2006
Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell linesMiltiadis Paliouras, Eleftherios P Diamandis
BMC Medicine|February 28, 2013
Fascin-1 is a novel biomarker of aggressiveness in some carcinomasVathany Kulasingam, Eleftherios P Diamandis
Biological Chemistry|November 19, 2009
Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semenNashmil Emami, Eleftherios P Diamandis
Clinical Chemistry|December 17, 2009
The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verificationShalini Makawita, Eleftherios P Diamandis
BMC Medicine|November 18, 2016
Genomic profiling for copy number changes in plasma of ovarian cancer patients - a new era for cancer diagnostics?Vathany Kulasingam, Eleftherios P Diamandis
Pageof 79

Showing results (61-70 of 787) with videos related to

Sort By:
Pageof 79
Clinical Biochemistry|April 25, 2017
The emerging landscape of scientific publishingClare Fiala, Eleftherios P Diamandis
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 3, 2008
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expressionMiltiadis Paliouras, Eleftherios P Diamandis
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancerK Angelopoulou, E P Diamandis
BMC Medicine|October 5, 2018
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detectionClare Fiala, Eleftherios P Diamandis
Clinical Chemistry|June 5, 2016
Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for AntidopingNatasha Musrap, Eleftherios P Diamandis
Breast Cancer Research and Treatment|August 10, 2006
Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell linesMiltiadis Paliouras, Eleftherios P Diamandis
BMC Medicine|February 28, 2013
Fascin-1 is a novel biomarker of aggressiveness in some carcinomasVathany Kulasingam, Eleftherios P Diamandis
Biological Chemistry|November 19, 2009
Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGF beta 1 in semenNashmil Emami, Eleftherios P Diamandis
Clinical Chemistry|December 17, 2009
The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verificationShalini Makawita, Eleftherios P Diamandis
BMC Medicine|November 18, 2016
Genomic profiling for copy number changes in plasma of ovarian cancer patients - a new era for cancer diagnostics?Vathany Kulasingam, Eleftherios P Diamandis
Pageof 79